» Articles » PMID: 28090352

Prevalence of Obesity in Malta

Overview
Journal Obes Sci Pract
Date 2017 Jan 17
PMID 28090352
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity is a global epidemic with the Mediterranean island of Malta being no exception. The World Health Organization (WHO) has identified Malta as one of the European countries with the highest obesity prevalence.

Method: A cross-sectional study was conducted (2014-2016) under the auspices of the University of Malta. The prevalence of overweight-obesity in Malta was calculated and then age stratified for comparisons with previous studies.

Results: The study identified 69.75% (95% CI: 68.32-71.18) of the Maltese population to be either overweight or obese. The men overweight/obese prevalence (76.28% 95% CI: 74.41-78.14) was statistically higher than that for women (63.06% 95% CI: 60.92-65.20) ( = 0.0001). Age stratification revealed that both genders had the highest overweight prevalence rates between 55 and 64 years (Men = 23.25% 95% CI: 20.43-26.33; Women = 24.68% 95% CI: 21.44-28.22). Men obesity prevalence rates were highest in the 35 to 44 years group (22.52% 95% CI: 19.65-25.68) while for women it was highest in the 55 to 64 years group (28.90%, 95% CI: 25.44-30.63).

Conclusion: Over a 35-year period, an overall decrease in the normal and overweight BMI categories occurred with an increase in the prevalence of obesity. An exception was observed in the women, where the prevalence of normal BMI increased over this time period. Also, it appears that while the total population obesity prevalence increased (for 2016), a percentage of the women have shifted from an obese to an overweight status.

Citing Articles

How does body mass index impact self-perceived health? A pan-European analysis of the European Health Interview Survey Wave 2.

Narciso J, Croome N BMJ Nutr Prev Health. 2023; 5(2):235-242.

PMID: 36619340 PMC: 9813638. DOI: 10.1136/bmjnph-2022-000439.


The Maleth program: Malta's first space mission discoveries on the microbiome of diabetic foot ulcers.

Gatt C, Tierney B, Madrigal P, Mason C, Beheshti A, Telzerow A Heliyon. 2022; 8(12):e12075.

PMID: 36544819 PMC: 9761711. DOI: 10.1016/j.heliyon.2022.e12075.


The accuracy of antenatal ultrasound screening in Malta: a population-based study.

Myatt J, Gatt M, Cordina M, Grech V, Attard-Montalto S J Turk Ger Gynecol Assoc. 2022; 23(4):222-232.

PMID: 36285879 PMC: 9743353. DOI: 10.4274/jtgga.galenos.2022.2022-4-1.


Insight into the Occurrence of Common Non-communicable Diseases at a Population Level and the Potential Impact During the Coronavirus Pandemic - a Need for a Syndemic Healthcare Approach?.

Cuschieri S, Grech S SN Compr Clin Med. 2021; 3(12):2393-2400.

PMID: 34568765 PMC: 8455231. DOI: 10.1007/s42399-021-01064-2.


Mapping the burden of diabetes in five small countries in Europe and setting the agenda for health policy and strategic action.

Cuschieri S, Pallari E, Terzic N, AlKerwi A, Sigurdardottir A Health Res Policy Syst. 2021; 19(1):43.

PMID: 33781266 PMC: 8006502. DOI: 10.1186/s12961-020-00665-y.


References
1.
Doak C, Wijnhoven T, Schokker D, Visscher T, Seidell J . Age standardization in mapping adult overweight and obesity trends in the WHO European Region. Obes Rev. 2011; 13(2):174-91. DOI: 10.1111/j.1467-789X.2011.00943.x. View

2.
Webber L, Divajeva D, Marsh T, McPherson K, Brown M, Galea G . The future burden of obesity-related diseases in the 53 WHO European-Region countries and the impact of effective interventions: a modelling study. BMJ Open. 2014; 4(7):e004787. PMC: 4120328. DOI: 10.1136/bmjopen-2014-004787. View

3.
Cuschieri S, Vassallo J, Calleja N, Camilleri R, Borg A, Bonnici G . Prevalence of obesity in Malta. Obes Sci Pract. 2017; 2(4):466-470. PMC: 5192534. DOI: 10.1002/osp4.77. View

4.
. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View

5.
Lifshitz F, Lifshitz J . Globesity: the root causes of the obesity epidemic in the USA and now worldwide. Pediatr Endocrinol Rev. 2014; 12(1):17-34. View